|
|
(State or Other Jurisdiction of Incorporation)
|
(I.R.S. Employer Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
Exhibit
Number |
|
Description
|
99.1
99.2
|
Press Release dated November 15, 2022.
Press Release dated November 15, 2022.
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
BERRY GLOBAL GROUP, INC.
(Registrant)
|
|||
Dated: November 15, 2022
|
By:
|
/s/ Jason K. Greene |
|
Name: |
Jason K. Greene |
||
Title: |
Executive Vice President,
Chief Legal Officer and Secretary
|
||
|
News Release
|
|
|
|
Fourth Quarter Highlights
(all comparisons made to the September 2021 quarter, adjusted for currency and divestitures)
|
• |
Net sales of $3.4 billion
|
• |
Operating income of $336 million; Operating EBITDA of $539 million, a 9% increase
|
• |
Earnings per share of $1.85; record adjusted earnings per share of $2.19, an 18% increase
|
|
Fiscal Year Highlights
(all comparisons made to fiscal year 2021, adjusted for currency and divestitures)
|
• |
Record net sales of $14.5 billion, a 10% increase |
• | Operating income of $1.2 billion; Operating EBITDA of $2.1 billion |
• |
Record earnings per share of $5.77; record adjusted earnings per share of $7.40, a 7% increase |
• | Cash flow from operations of $1.56 billion; free cash flow of $876 million, +$125 million above guidance |
• |
$709 million of share repurchases, a 9% reduction in total shares outstanding
|
|
Fiscal Year 2023 Guidance
(based on information available as of November 15, 2022)
|
• |
Adjusted earnings per share range of $7.30 - $7.80, 8% expected mid-point growth versus comparable prior year |
• | Cash flow from operations range of $1.4 - $1.5 billion; free cash flow range of $800 - $900 million expected |
• | Initiated $0.25 per share quarterly cash dividend, capital allocation milestone |
• | Anticipate returning at least $700 million of capital to shareholders through share repurchases and dividends |
Key Financials (1)
|
Quarterly Periods Ended
|
Fiscal Year Ended
|
||||||||||||||
GAAP results (in millions, except per share data)
|
October 1, 2022
|
October 2, 2021
|
October 1, 2022
|
October 2, 2021
|
||||||||||||
Net sales
|
$
|
3,421
|
$
|
3,669
|
$
|
14,495
|
$
|
13,850
|
||||||||
Operating income
|
336
|
312
|
1,242
|
1,292
|
||||||||||||
EPS (diluted)
|
1.85
|
1.64
|
5.77
|
5.30
|
Quarterly Periods Ended
|
||||||||||||||||||||
October 1, 2022
|
October 2, 2021
|
October 2, 2021
|
||||||||||||||||||
Adjusted non-GAAP results
|
Reported
|
Comparable
|
As reported
change
|
Comparable basis
change
|
||||||||||||||||
Net sales
|
$
|
3,421
|
$
|
3,669
|
$
|
3,441
|
(7
|
%)
|
(1
|
%)
|
||||||||||
Operating EBITDA
|
539
|
530
|
494
|
2
|
%
|
9
|
%
|
|||||||||||||
Adjusted EPS (diluted)
|
2.19
|
1.89
|
1.85
|
16
|
%
|
18
|
%
|
Fiscal Year Ended
|
||||||||||||||||||||
October 1, 2022
|
October 2, 2021
|
October 2, 2021
|
||||||||||||||||||
Adjusted non-GAAP results
|
Reported
|
Comparable
|
As reported
change
|
Comparable basis
change
|
||||||||||||||||
Net sales
|
$
|
14,495
|
$
|
13,850
|
$
|
13,180
|
5
|
%
|
10
|
%
|
||||||||||
Operating EBITDA
|
2,101
|
2,224
|
2,118
|
(6
|
%)
|
(1
|
%)
|
|||||||||||||
Adjusted EPS (diluted)
|
7.40
|
7.21
|
6.92
|
3
|
%
|
7
|
%
|
Fiscal 2023
|
||
Adjusted earnings per diluted share
|
$7.30-$7.80
|
|
Free cash flow
|
$800-$900 million
|
Quarterly Period Ended
|
Fiscal Year Ended
|
|||||||||||||||
October 1,
2022
|
October 2,
2021
|
October 1,
2022
|
October 2,
2021
|
|||||||||||||
Net sales
|
$
|
3,421
|
$
|
3,669
|
$
|
14,495
|
$
|
13,850
|
||||||||
Costs and expenses:
|
||||||||||||||||
Cost of goods sold
|
2,834
|
3,078
|
12,123
|
11,352
|
||||||||||||
Selling, general and administrative
|
185
|
199
|
850
|
867
|
||||||||||||
Amortization of intangibles
|
61
|
69
|
257
|
288
|
||||||||||||
Restructuring and transaction activities
|
5
|
11
|
23
|
51
|
||||||||||||
Operating income
|
336
|
312
|
1,242
|
1,292
|
||||||||||||
Other expense
|
9
|
6
|
22
|
51
|
||||||||||||
Interest expense
|
74
|
79
|
286
|
336
|
||||||||||||
Income before income taxes
|
253
|
227
|
934
|
905
|
||||||||||||
Income tax expense (benefit)
|
20
|
(1
|
)
|
168
|
172
|
|||||||||||
Net income
|
$
|
233
|
$
|
228
|
$
|
766
|
$
|
733
|
||||||||
Net income per share:
|
||||||||||||||||
Basic
|
$
|
1.87
|
$
|
1.68
|
$
|
5.87
|
$
|
5.45
|
||||||||
Diluted
|
1.85
|
1.64
|
5.77
|
5.30
|
||||||||||||
Outstanding weighted-average shares: (in millions)
|
||||||||||||||||
Basic
|
124.7
|
135.4
|
130.6
|
134.6
|
||||||||||||
Diluted
|
126.0
|
138.7
|
132.8
|
138.3
|
October 1, 2022
|
October 2, 2021
|
|||||||
Assets:
|
||||||||
Cash and cash equivalents
|
$
|
1,410
|
$
|
1,091
|
||||
Accounts receivable
|
1,777
|
1,879
|
||||||
Inventories
|
1,802
|
1,828
|
||||||
Other current assets
|
175
|
217
|
||||||
Property, plant, and equipment
|
4,342
|
4,756
|
||||||
Goodwill, intangible assets, and other long-term assets
|
7,450
|
8,111
|
||||||
Total assets
|
$
|
16,956
|
$
|
17,882
|
||||
Liabilities and Stockholders' Equity:
|
||||||||
Current liabilities, excluding current debt
|
$
|
2,831
|
$
|
3,165
|
||||
Current and long-term debt
|
9,255
|
9,460
|
||||||
Other long-term liabilities
|
1,674
|
2,077
|
||||||
Stockholders’ equity
|
3,196
|
3,180
|
||||||
Total liabilities and stockholders' equity
|
$
|
16,956
|
$
|
17,882
|
Fiscal Year Ended
|
||||||||
October 1, 2022
|
October 2, 2021
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
766
|
$
|
733
|
||||
Adjustments to reconcile net cash provided by operating activities:
|
||||||||
Depreciation
|
562
|
566
|
||||||
Amortization of intangibles
|
257
|
288
|
||||||
Non-cash interest
|
6
|
32
|
||||||
Deferred income tax
|
(48
|
)
|
(73
|
)
|
||||
Share-based compensation expense
|
39
|
40
|
||||||
Settlement of derivatives
|
201
|
-
|
||||||
Other non-cash operating activities, net
|
(22
|
)
|
49
|
|||||
Changes in working capital
|
(198
|
)
|
(55
|
)
|
||||
Net cash from operating activities
|
1,563
|
1,580
|
||||||
Cash flows from investing activities:
|
||||||||
Additions to property, plant, and equipment, net
|
(687
|
)
|
(676
|
)
|
||||
Settlement of net investment hedges
|
76
|
-
|
||||||
Divestiture of businesses
|
128
|
165
|
||||||
Net cash from investing activities
|
(483
|
)
|
(511
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayments on long-term borrowings
|
(22
|
)
|
(3,496
|
)
|
||||
Proceeds from long-term borrowings
|
-
|
2,716
|
||||||
Proceeds from issuance of common stock
|
27
|
60
|
||||||
Debt financing costs
|
-
|
(21
|
)
|
|||||
Repurchase of common stock
|
(709
|
)
|
-
|
|||||
Net cash from financing activities
|
(704
|
)
|
(741
|
)
|
||||
Effect of currency translation on cash
|
(57
|
)
|
13
|
|||||
Net change in cash and cash equivalents
|
319
|
341
|
||||||
Cash and cash equivalents at beginning of period
|
1,091
|
750
|
||||||
Cash and cash equivalents at end of period
|
$
|
1,410
|
$
|
1,091
|
Quarterly Period Ended October 1, 2022
|
||||||||||||||||||||
Consumer Packaging - International
|
Consumer Packaging- North America
|
Health, Hygiene & Specialties
|
Engineered Materials
|
Total
|
||||||||||||||||
Net sales
|
$
|
1,003
|
$
|
888
|
$
|
738
|
$
|
792
|
$
|
3,421
|
||||||||||
Operating income
|
$
|
98
|
$
|
103
|
$
|
44
|
$
|
91
|
$
|
336
|
||||||||||
Depreciation and amortization
|
75
|
53
|
43
|
28
|
199
|
|||||||||||||||
Restructuring and transaction activities (1)
|
—
|
2
|
3
|
—
|
5
|
|||||||||||||||
Other non-cash charges
|
(1
|
)
|
—
|
—
|
—
|
(1
|
)
|
|||||||||||||
Operating EBITDA
|
$
|
172
|
$
|
158
|
$
|
90
|
$
|
119
|
$
|
539
|
Quarterly Period Ended October 2, 2021
|
||||||||||||||||||||
Consumer Packaging - International
|
Consumer Packaging - North America
|
Health, Hygiene & Specialties
|
Engineered Materials
|
Total
|
||||||||||||||||
Reported net sales
|
$
|
1,099
|
$
|
878
|
$
|
809
|
$
|
883
|
$
|
3,669
|
||||||||||
Foreign currency and divestitures
|
(173
|
)
|
—
|
(24
|
)
|
(31
|
)
|
(228
|
)
|
|||||||||||
Comparable net sales (2)
|
$
|
926
|
$
|
878
|
$
|
785
|
$
|
852
|
$
|
3,441
|
||||||||||
Operating income
|
$
|
102
|
$
|
64
|
$
|
76
|
$
|
70
|
$
|
312
|
||||||||||
Depreciation and amortization
|
83
|
60
|
47
|
25
|
215
|
|||||||||||||||
Restructuring and transaction activities (1)
|
12
|
(1
|
)
|
—
|
—
|
11
|
||||||||||||||
Other non-cash charges
|
(11
|
)
|
1
|
1
|
1
|
(8
|
)
|
|||||||||||||
Operating EBITDA (as reported)
|
$
|
186
|
$
|
124
|
$
|
124
|
$
|
96
|
$
|
530
|
||||||||||
Foreign currency and divestitures
|
(29
|
)
|
—
|
(4
|
)
|
(3
|
)
|
(36
|
)
|
|||||||||||
Comparable operating EBITDA (2)
|
$
|
157
|
$
|
124
|
$
|
120
|
$
|
93
|
$
|
494
|
Fiscal Year Ended October 1, 2022
|
||||||||||||||||||||
Consumer Packaging - International
|
Consumer Packaging- North America
|
Health, Hygiene & Specialties
|
Engineered Materials
|
Total
|
||||||||||||||||
Net sales
|
$
|
4,293
|
$
|
3,548
|
$
|
3,166
|
$
|
3,488
|
$
|
14,495
|
||||||||||
Operating income
|
$
|
346
|
$
|
338
|
$
|
230
|
$
|
328
|
$
|
1,242
|
||||||||||
Depreciation and amortization
|
317
|
214
|
176
|
112
|
819
|
|||||||||||||||
Restructuring and transaction activities (1)
|
10
|
5
|
6
|
2
|
23
|
|||||||||||||||
Other non-cash charges
|
(5
|
)
|
8
|
8
|
6
|
17
|
||||||||||||||
Operating EBITDA
|
$
|
668
|
$
|
565
|
$
|
420
|
$
|
448
|
$
|
2,101
|
Fiscal Year Ended October 2, 2021
|
||||||||||||||||||||
Consumer Packaging - International
|
Consumer Packaging - North America
|
Health, Hygiene & Specialties
|
Engineered Materials
|
Total
|
||||||||||||||||
Reported net sales
|
$
|
4,242
|
$
|
3,141
|
$
|
3,158
|
$
|
3,309
|
$
|
13,850
|
||||||||||
Foreign currency and divestitures
|
(388
|
)
|
(40
|
)
|
(92
|
)
|
(150
|
)
|
(670
|
)
|
||||||||||
Comparable net sales (2)
|
$
|
3,854
|
$
|
3,101
|
$
|
3,066
|
$
|
3,159
|
$
|
13,180
|
||||||||||
Operating income
|
$
|
317
|
$
|
276
|
$
|
398
|
$
|
301
|
$
|
1,292
|
||||||||||
Depreciation and amortization
|
341
|
224
|
177
|
112
|
854
|
|||||||||||||||
Restructuring and transaction activities (1)
|
56
|
—
|
(1
|
)
|
(4
|
)
|
51
|
|||||||||||||
Other non-cash charges
|
—
|
10
|
9
|
8
|
27
|
|||||||||||||||
Operating EBITDA (as reported)
|
$
|
714
|
$
|
510
|
$
|
583
|
$
|
417
|
$
|
2,224
|
||||||||||
Foreign currency and divestitures
|
(60
|
)
|
(8
|
)
|
(17
|
)
|
(21
|
)
|
(106
|
)
|
||||||||||
Comparable operating EBITDA (2)
|
$
|
654
|
$
|
502
|
$
|
566
|
$
|
396
|
$
|
2,118
|
||||||||||
(1)
|
Primarily includes transaction activity costs related to the RPC acquisition.
|
(2)
|
The prior year comparable basis change excludes the impacts of foreign currency and recent divestitures. Further details
related to non-GAAP measures and reconciliations can be found under our “Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release.
Note: For comparison purposes to the fiscal year 2021, Operating EBITDA margins for the fiscal year ended October 1,
2022, would be increased by 190 basis points (to 16.4%) when adjusted for the impact of inflation on net sales of $1.65 billion.
|
Quarterly Period Ended
|
Fiscal Year Ended
|
|||||||||||||||
October 1, 2022
|
October 2, 2021
|
October 1, 2022
|
October 2, 2021
|
|||||||||||||
Net income
|
$
|
233
|
$
|
228
|
$
|
766
|
$
|
733
|
||||||||
Add: other expense
|
9
|
6
|
22
|
51
|
||||||||||||
Add: interest expense
|
74
|
79
|
286
|
336
|
||||||||||||
Add: income tax expense
|
20
|
(1
|
)
|
168
|
172
|
|||||||||||
Operating income
|
$
|
336
|
$
|
312
|
$
|
1,242
|
$
|
1,292
|
||||||||
Add: restructuring and transaction activities
|
5
|
11
|
23
|
51
|
||||||||||||
Add: other non-cash charges
|
(1
|
)
|
(8
|
)
|
17
|
27
|
||||||||||
Adjusted operating income (4)
|
$
|
340
|
$
|
315
|
$
|
1,282
|
$
|
1,370
|
||||||||
Add: depreciation
|
138
|
146
|
562
|
566
|
||||||||||||
Add: amortization of intangibles
|
61
|
69
|
257
|
288
|
||||||||||||
Operating EBITDA (4)
|
$
|
539
|
$
|
530
|
$
|
2,101
|
$
|
2,224
|
||||||||
Cash flow from operating activities
|
$
|
1,218
|
$
|
668
|
$
|
1,563
|
$
|
1,580
|
||||||||
Net additions to property, plant, and equipment
|
(129
|
)
|
(156
|
)
|
(687
|
)
|
(676
|
)
|
||||||||
Free cash flow (4)
|
$
|
1,089
|
$
|
512
|
$
|
876
|
$
|
904
|
||||||||
Net income per diluted share
|
$
|
1.85
|
$
|
1.64
|
$
|
5.77
|
$
|
5.30
|
||||||||
Other expense, net
|
0.07
|
0.04
|
0.17
|
0.37
|
||||||||||||
Restructuring and transaction activities
|
0.04
|
0.08
|
0.17
|
0.37
|
||||||||||||
Amortization of intangibles from acquisitions (1)
|
0.48
|
0.50
|
1.94
|
2.08
|
||||||||||||
Non-comparable tax items (2)
|
(0.14
|
)
|
(0.22
|
)
|
(0.13
|
)
|
(0.24
|
)
|
||||||||
Income tax impact on items above
|
(0.11
|
)
|
(0.16
|
)
|
(0.52
|
)
|
(0.67
|
)
|
||||||||
Adjusted net income per diluted share (4)
|
$
|
2.19
|
$
|
1.89
|
$
|
7.40
|
$
|
7.21
|
||||||||
Foreign currency and divestitures
|
(0.04
|
)
|
(0.29
|
)
|
||||||||||||
Comparable adjusted net income per diluted share (4)
|
$
|
1.85
|
$
|
6.92
|
||||||||||||
Estimated Fiscal 2023
|
||||||||||||||||
Cash flow from operating activities
|
$
|
1,400-$1,500
|
|
|
|
|||||||||||
Net additions to property, plant, and equipment
|
(600
|
)
|
||||||||||||||
Free cash flow (4)
|
$
|
800-$900
|
||||||||||||||
Comparable Y-O-Y Growth (FY22 actual results to FY23 guidance mid-point)
|
||||||||||||||||
Adj. EPS
|
Op. EBITDA
|
|||||||||||||||
FY’22 actual
|
$
|
7.40
|
$
|
2,101
|
||||||||||||
Foreign currency and divestitures (3)
|
(0.40
|
)
|
(95
|
)
|
||||||||||||
FY’22 comparable (4)
|
$
|
7.00
|
$
|
2,006
|
||||||||||||
FY’23 (at
the mid-point of guidance expectation)
|
$
|
7.55
|
$
|
2,100
|
||||||||||||
Expected year-over-year comparable growth (4)
|
~8%
|
~5%
|
(1)
|
Amortization of intangibles from acquisition are added back to better align our calculation of adjusted
EPS with peers.
|
(2)
|
During the 2022 and 2021 fiscal years, the Company obtained certain tax benefits of $18 million and $30 million, respectively, deemed as
non-comparable. Additionally, we included the prior year extra days (which was in the December 2021 quarter only), in the non-comparable line.
|
(3)
|
The FY 2022 comparable basis change excludes the impacts of foreign currency (as of October 2022) and recent divestitures.
|
(4)
|
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally
accepted in the United States (“GAAP”). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP.
Organic sales growth and comparable basis measures exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in
our industry, limiting their usefulness as comparative measures. Berry’s management believes that adjusted net income and other non-GAAP financial measures are useful to our investors because they allow for a better
period-over-period comparison of operating results by removing the impact of items that, in management’s view, do not reflect our core operating performance.
We define “free cash flow” as cash flow from operating activities, less net additions to property, plant, and equipment. We believe free cash flow is useful to an
investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe free
cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash.
Adjusted EBITDA is used by our lenders for debt covenant compliance purposes. We also use Adjusted EBITDA, Operating EBITDA, and
comparable basis measures, among other measures, to evaluate management performance and in determining performance-based compensation. Operating EBITDA is a measure widely used by investors, securities analysts, and other
interested parties in our industry to measure a company’s performance. We also believe EBITDA and Adjusted net income are useful to an investor in evaluating our performance without regard to revenue and expense recognition,
which can vary depending upon accounting methods.
(BERY-F)
|
|
News Release
|
|
|
Investor Contact:
Dustin Stilwell
1+812.306.2964
ir@berryglobal.com
|
Media Contact:
Eva Schmitz
1+812.306.2424
evaschmitz@berryglobal.com
|